WO2005037318A3 - Treatment of arthritic conditions, chronic inflammation or pain - Google Patents
Treatment of arthritic conditions, chronic inflammation or pain Download PDFInfo
- Publication number
- WO2005037318A3 WO2005037318A3 PCT/US2004/034184 US2004034184W WO2005037318A3 WO 2005037318 A3 WO2005037318 A3 WO 2005037318A3 US 2004034184 W US2004034184 W US 2004034184W WO 2005037318 A3 WO2005037318 A3 WO 2005037318A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pain
- arthritic conditions
- treatment
- opioid antagonists
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004281153A AU2004281153A1 (en) | 2003-10-15 | 2004-10-15 | Treatment of arthritic conditions, chronic inflammation or pain |
CA002542395A CA2542395A1 (en) | 2003-10-15 | 2004-10-15 | Treatment of arthritic conditions, chronic inflammation or pain |
EP04795362A EP1680143A2 (en) | 2003-10-15 | 2004-10-15 | Treatment of arthritic conditions, chronic inflammation or pain |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51184103P | 2003-10-15 | 2003-10-15 | |
US60/511,841 | 2003-10-15 | ||
US56618904P | 2004-04-27 | 2004-04-27 | |
US60/566,189 | 2004-04-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005037318A2 WO2005037318A2 (en) | 2005-04-28 |
WO2005037318A3 true WO2005037318A3 (en) | 2005-06-09 |
Family
ID=34468007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/034184 WO2005037318A2 (en) | 2003-10-15 | 2004-10-15 | Treatment of arthritic conditions, chronic inflammation or pain |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1680143A2 (en) |
AU (1) | AU2004281153A1 (en) |
CA (1) | CA2542395A1 (en) |
WO (1) | WO2005037318A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1897544A1 (en) * | 2006-09-05 | 2008-03-12 | Holger Lars Hermann | Opioid agonist and antagonist combinations |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4769372A (en) * | 1986-06-18 | 1988-09-06 | The Rockefeller University | Method of treating patients suffering from chronic pain or chronic cough |
US5472943A (en) * | 1992-09-21 | 1995-12-05 | Albert Einstein College Of Medicine Of Yeshiva University, | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists |
WO1999032119A1 (en) * | 1997-12-22 | 1999-07-01 | Euro-Celtique, S.A. | Opioid agonist/antagonist combinations |
WO2001058447A1 (en) * | 2000-02-08 | 2001-08-16 | Euro-Celtique, S.A. | Controlled-release compositions containing opioid agonist and antagonist |
WO2001085150A2 (en) * | 2000-05-05 | 2001-11-15 | Pain Therapeutics, Inc. | Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists |
WO2003013525A1 (en) * | 2001-08-06 | 2003-02-20 | Euro-Celtique S.A. | Opioid agonist formulations with releasable and sequestered antagonist |
US20030191147A1 (en) * | 2002-04-09 | 2003-10-09 | Barry Sherman | Opioid antagonist compositions and dosage forms |
US20040110781A1 (en) * | 2002-12-05 | 2004-06-10 | Harmon Troy M. | Pharmaceutical compositions containing indistinguishable drug components |
WO2004091593A2 (en) * | 2003-04-14 | 2004-10-28 | Pain Therapeutics, Inc. | Methods for the treatment of pain comprising opioid antagonists |
-
2004
- 2004-10-15 WO PCT/US2004/034184 patent/WO2005037318A2/en active Application Filing
- 2004-10-15 CA CA002542395A patent/CA2542395A1/en not_active Abandoned
- 2004-10-15 EP EP04795362A patent/EP1680143A2/en not_active Withdrawn
- 2004-10-15 AU AU2004281153A patent/AU2004281153A1/en not_active Abandoned
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4769372A (en) * | 1986-06-18 | 1988-09-06 | The Rockefeller University | Method of treating patients suffering from chronic pain or chronic cough |
US5472943A (en) * | 1992-09-21 | 1995-12-05 | Albert Einstein College Of Medicine Of Yeshiva University, | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists |
WO1999032119A1 (en) * | 1997-12-22 | 1999-07-01 | Euro-Celtique, S.A. | Opioid agonist/antagonist combinations |
WO2001058447A1 (en) * | 2000-02-08 | 2001-08-16 | Euro-Celtique, S.A. | Controlled-release compositions containing opioid agonist and antagonist |
WO2001085150A2 (en) * | 2000-05-05 | 2001-11-15 | Pain Therapeutics, Inc. | Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists |
WO2003013525A1 (en) * | 2001-08-06 | 2003-02-20 | Euro-Celtique S.A. | Opioid agonist formulations with releasable and sequestered antagonist |
US20030191147A1 (en) * | 2002-04-09 | 2003-10-09 | Barry Sherman | Opioid antagonist compositions and dosage forms |
US20040110781A1 (en) * | 2002-12-05 | 2004-06-10 | Harmon Troy M. | Pharmaceutical compositions containing indistinguishable drug components |
WO2004091593A2 (en) * | 2003-04-14 | 2004-10-28 | Pain Therapeutics, Inc. | Methods for the treatment of pain comprising opioid antagonists |
Also Published As
Publication number | Publication date |
---|---|
WO2005037318A2 (en) | 2005-04-28 |
AU2004281153A1 (en) | 2005-04-28 |
CA2542395A1 (en) | 2005-04-28 |
EP1680143A2 (en) | 2006-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005107726A3 (en) | Method for the treatment of back pain | |
WO2003070191A3 (en) | Tamper-resistant transdermal opioid delivery devices | |
WO2004000354A3 (en) | Method of treating the syndrome of lipodystrophy | |
TW200631578A (en) | Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury | |
DE602004005076D1 (en) | COEXTRUDED SAFETY DOSAGE FORM WITH AN ACTIVE AGENT AND ADVERSE AGENT AND METHOD OF MANUFACTURING THEREOF | |
WO2004096122A3 (en) | Use of ngf antagonists and opioids for treating pain | |
WO2006074265A3 (en) | Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders | |
WO2005041925A3 (en) | Compositions and dosage forms for enhanced absorption | |
WO2006036770A3 (en) | Combination therapy for the treatment of obesity | |
MX2007006066A (en) | Jnk inhibitors for treatment of cns injury. | |
BRPI0412557A (en) | pharmaceutical dosage form of cardiovascular events | |
WO2006049933A3 (en) | Compositions and methods for the treatment of obesity and sexual dysfunction | |
WO2002099388A3 (en) | Benzodiazepine bradykinin antagonists | |
WO2004091540A3 (en) | Methods of treating pain and compositions for use therefor | |
MXPA06000705A (en) | Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders. | |
WO2005107467A3 (en) | Compositions including opioids and methods of their use in treating pain | |
WO2007006732A8 (en) | Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist) | |
WO2005082070A3 (en) | Compositions and methods for the systemic treatment of arthritis | |
MXPA06002722A (en) | A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug. | |
MXPA05012358A (en) | Pharmaceutical combination comprising modafinil and another drug. | |
ATE465735T1 (en) | USE OF A COMBINATION OF MORPHINE AND AT LEAST ONE OPIATE ANTAGONIST FOR THE TREATMENT OF OPIATE DEPENDENCE AND FOR THE PREVENTION OF NON-ORAL OPIATE ABUSE IN OPIATE ADDICTS | |
WO2005092442A3 (en) | Method and compositions for treatment of chronic neuropathic pain | |
AP2002002501A0 (en) | Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog. | |
WO2000053148A3 (en) | Methods and compositions for treating erectile dysfunction | |
NO20042758L (en) | Procedure for treating a patient requiring analgesia. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004281153 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2542395 Country of ref document: CA Ref document number: 2004795362 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2004281153 Country of ref document: AU Date of ref document: 20041015 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004281153 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004795362 Country of ref document: EP |